A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index


About Antigenics:

Antigenics Inc. is a biotechnology firm developing products to treat cancers, infectious diseases and autoimmune disorders.

Lead Products in Development at Antigenics

Oncophage® (HSPPC-96) and AG-858 (HSPPC-70) are investigational personalized cancer vaccines based on Antigenics’ heat shock protein technology. Oncophage has received fast track and orphan drug designations from the US Food and Drug Administration for both kidney cancer and metastatic melanoma.

AG-858 vaccine is in clinical trails in combination treatment for chronic myelogenous leukemia.

Both Oncophage® (HSPPC-96) and AG-858 (HSPPC-70) vaccines are designed to reprogram the immune system to target cancer cells while leaving healthy cells unaffected.

Aroplatin is currently being evaluated as a monotherapy in for colon cancer and advanced solid tumors.

AG-702 is an investigational vaccine for genital herpes treatment based on proprietary heat shock protein technology.

Ongoing clinical trials

More on Antigenics

Home Page

Key Statistics fo Antigenics

Basic Chart for Antigenics

Analyst Opinion

Analysts Estimates

Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.